Mod 5

Cards (132)

  • Antimicrobial agents

    Natural or synthetic substance that kills (bactericidal) or inhibits (bacteriostatic) growth of microorganisms
  • Types of antimicrobial agents
    • Antibacterial/antibiotic
    • Antiviral
    • Antifungal
    • Antiparasitic
  • Antibacterial agents classified by mechanism of action
    • Inhibitors of cell wall synthesis
    • Inhibitors of protein synthesis
    • Inhibitors of nucleic acid function or synthesis
    • Inhibitors of cell membrane function
    • Inhibitors of metabolism
  • Bacteriostatic
    Inhibits bacterial growth
  • Bactericidal
    Kills target organisms
  • Examples of bacteriostatic antibacterial agents
    • Chloramphenicol
    • Erythromycin and other macrolides
    • Clindamycin
    • Sulfonamides
    • Trimethoprim
    • Tetracyclines
    • Tigecycline
    • Linezolid
    • Quinupristin/dalfopristin
  • Examples of bactericidal antibacterial agents
    • Aminoglycosides
    • Beta-lactams
    • Vancomycin
    • Daptomycin
    • Teicoplanin
    • Quinolones
    • Rifampin
    • Metronidazole
  • Classification of antibiotics by source
    • Natural drugs
    • Semi-synthetic drugs
    • Synthetic drugs
  • Narrow-spectrum antibiotics

    Acting only on a single or a limited group of microorganisms
  • Extended-spectrum antibiotics

    Effective against gram-positive and also against a significant number of gram-negative bacteria
  • Broad-spectrum antibiotics

    Affect a wide variety of microbial species
  • Inhibitors of cell wall synthesis
    Beta-lactams bind enzymes involved in peptidoglycan production (PBPs)
    Glycopeptides bind to precursors of cell wall synthesis (e.g. vancomycin, bacitracin, teicoplanin, daptomycin)
  • Beta-lactam antibiotics

    • Penicillins (e.g. amoxicillin, ampicillin, dicloxacillin, indanyl, carbenicillin, methicillin, nafcillin, penicillin G, penicillin V, piperacillin, ticarcillin)
    Cephalosporins (1st gen: cefadroxil, cefazolin, cephalexin; 2nd gen: cefaclor, cefprozil, cefuroxime, cefoxitin; 3rd gen: cefdinir, cefixime, cefotaxime, ceftazidime, ceftibuten, ceftizoxime, ceftriaxone; 4th gen: cefepime)
    Carbapenems (ertapenem, imipenem, meropenem)
    Monobactams (aztreonam)
  • Beta-lactamase inhibitors

    Given with a beta-lactam antibiotic to provide effective treatment, have structural similarity with the beta-lactam antibiotics and function as substrate of beta-lactamase, thus reducing harm on the beta-lactam antibiotic (e.g. clavulanic acid, sulbactam, tazobactam)
  • Vancomycin
    Binds to D-Ala-D-Ala terminal of growing peptide chain, usually ineffective against gram-negative bacteria, used to treat methicillin-resistant Staphylococcus aureus (MRSA)
  • Inhibitors of protein synthesis
    Aminoglycosides bind to 30S ribosomal subunit
    Macrolide-lincosamide-streptogramin (MLS) group bind to 50S ribosomal subunit
    Ketolides bind to 50S ribosomal subunit
    Oxazolidinones bind to 50S ribosomal subunit
    Chloramphenicol binds 50S ribosomal subunit
    Tetracyclines bind 30S ribosomal subunit
    Glycylglycines bind to 30S ribosomal subunit
  • Abelardo B. Aguilar, a Filipino scientist, was "supposed to be" the discoverer of a powerful macrolide antibiotic erythromycin, but the pharmaceutical company Eli Lilly and Company filed for the patent and was granted in 1953
  • Inhibitors of DNA/RNA synthesis
    Fluoroquinolones inhibit DNA synthesis by binding DNA gyrases
    Metronidazole causes breakage of DNA strands
    Rifampin inhibits RNA synthesis by binding DNA-dependent, RNA polymerase
  • Inhibitors of other metabolic processes
    Nitrofurantoin may have several bacterial enzyme targets and directly damage DNA
    Polymyxins disrupt cell membrane
    Sulfonamides interfere with folic acid pathway by binding the enzyme dihydropteroate synthase
    Trimethoprim interferes with folic acid pathway by binding the enzyme dihydrofolate reductase
  • Anti-tuberculosis drugs
    • Rifampicin
    • Isoniazid
    • Pyrazinamide
    • Ethambutol
    • Streptomycin
  • Synergism
    Occurs when the antimicrobial activity of a combination of antimicrobial agents is greater than the activity of the individual agents alone
  • Antimicrobial resistance
    Ability of a microbe to resist effects of medication, may be environmentally-mediated or microorganism-mediated (intrinsic or acquired)
  • Biologic resistance

    Organism becomes less susceptible
  • Clinical resistance
    Susceptibility has been lost, drug is no longer effective
  • Impermeability
    Inability to penetrate the cell wall of bacteria, related to lipopolysaccharide and outer membrane proteins (porins)
  • Biofilms
    Decreased penetration of antibiotics, decreased oxygen and nutrients, formation of persister cells
  • Efflux
    Efflux pumps remove toxic substances from the cell
  • Enzymatic inactivation
    Beta-lactamases hydrolyze beta-lactam antibiotics, extended-spectrum beta-lactamases (ESBLs) can hydrolyze even newly developed beta-lactams
  • Target site modification
    Chromosomal mutations in penicillin-binding proteins (PBPs) or enzymatic alteration of ribosomal targets
  • Acquisition of new targets
    Acquire cellular targets with reduced affinity for the antibiotic, e.g. methicillin-resistant Staphylococcus aureus (MRSA)
  • Timeline of development of antibiotics vs. resistance
  • Antimicrobial susceptibility testing

    Test performed on bacteria isolated from clinical specimens to determine which antimicrobial agents might be effective in treating infections
  • Conventional susceptibility testing methods
    • Dilution tests (broth dilution, agar dilution)
    • Diffusion tests (disk agar diffusion, gradient diffusion)
  • Broth dilution method
    Serial dilution of antibiotic is prepared, and to each tube a standard amount of inoculum is added, determines MIC and can determine MBC
  • Minimum Inhibitory Concentration (MIC)
    Lowest concentration of antibiotic that inhibits growth
  • Minimum Bactericidal Concentration (MBC)
    Lowest concentration of antibiotic that kills 99.9% of bacteria
  • Susceptibility testing

    Also known as Antimicrobial Sensitivity Testing
  • Purpose of susceptibility testing

    Test performed on bacteria isolated from clinical specimens to determine which antimicrobial agents might be effective in treating infections caused by the bacteria
  • Conventional susceptibility testing methods
    • Dilution tests
    • Diffusion tests
  • Broth dilution method

    Serial dilution of antibiotic is prepared, and to each tube a standard amount of inoculum is added